Loading, please wait....jpg)
CONTINUING PHARMACY EDUCATION
Clean Data and Polished Compliance: Leveraging AI Diversion Software
to Optimize Alerts and Improve Controlled Substance Processes
Speaker: Bethanie Gamble, PharmD, Diversion Coordinator – Upstate, Prisma Health Greenville Memorial Hospital, Greenville, SC
ACPE Universal Program ID# 0122-0000-26-020-H04-P/T
1 Contact Hours [0.1 CEU]
Release Date: January 28, 2026
Expiration Date: January 28, 2029
Fee
$0.00
CE Hours
1.00
CE Units
0.100
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists and Pharmacy Technicians
Accreditation(s)
|
Premier, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
Clean Data and Polished Compliance: Leveraging AI Diversion Software to Optimize Alerts and Improve Controlled Substance Processes
Clean Data and Polished Compliance: Leveraging AI Diversion Software to Optimize Alerts and Improve Controlled Substance Processes
There are 2 steps to completing this home-study CE.
Step 1: Watch the video presentation in its entirety.
Step 2: Click on "Take the Test" to complete the post-test and evaluation.
Please Note: A handout is provided. Please print it out and follow along with the audio recording.
Objectives
- Identify specific data streams and unique workflows that should be captured within your organization’s artificial intelligence (AI) diversion software.
- Outline diversion data cleaning techniques within a software solution and recognize the value these methods provide in mitigating the risk of identifying false positive risky team members.
- Recognize specific categories involved in controlled substance handling that can increase ‘noise’ within AI diversion software.
- Discuss ways to address those concerns with the goal of differentiating between compliance issues or diversion activity.
- Describe how leveraging data to identify cultural issues of non-compliance can be utilized to drive unique process change and create key performance indicators (KPI).
- Discuss how to lead a drug diversion response team into more escalated steps when perceived risk cannot be explained.
Speaker(s)/Author(s)
|
Bethanie Gamble, PharmD
|
Activity Number
0122-0000-26-020-H04-P/T
Release Date:
Jan 28, 2026
Credit Expiration Date:
Jan 28, 2029
CE Hours
1.00